Overview
- 24 inspections across 23 sites are on record.
- 15 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-16.
At a glance
Inspections
24
Sites
23
Observations
15
Career since
Jun 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Grato Holdings, Inc. | 16 Apr 2026 | Human Drugs | On file |
| Hybio Pharmaceutical Co., Ltd. | 5 Dec 2025 | Human Drugs | |
| Menasha Packaging Company LLC | 14 Nov 2025 | Human Drugs | |
| LTS Therapy Systems, LLC | 30 Sep 2025 | Human Drugs | On file |
| North American Science Associates, LLC | 21 Aug 2025 | Human Drugs |
Sites inspected
Grato Holdings, Inc.Woodbine, United States1 insp.
Hybio Pharmaceutical Co., Ltd.Shenzhen, China1 insp.
Menasha Packaging Company LLCEdwardsville, United States1 insp.
LTS Therapy Systems, LLCSaint Paul, United States1 insp.
North American Science Associates, LLCSaint Paul, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Robin P Mathew3 shared
Kevin P Regan3 shared
Beatrix D Hippe2 shared
Michele Perry-Williams2 shared
JeanClaude Garay1 shared
Elizabeth R Bloom1 shared
Travis V Hull1 shared
Robert J Ham1 shared
Beatrix D Arevalo1 shared
Rafeeq A Habeeb1 shared
Full investigator report
Get the verbatim findings behind Soyinka S Eneng's 15 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site